APA (7th ed.) Citation

Lee, J., Kang, B., Moon, J. S., Um, T., Choi, J. E., Lee, M., . . . Park, H. Y. (2026). Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery. Cancers, 18(6), 919. https://doi.org/10.3390/cancers18060919

Chicago Style (17th ed.) Citation

Lee, Jeeyeon, et al. "Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery." Cancers 18, no. 6 (2026): 919. https://doi.org/10.3390/cancers18060919.

MLA (9th ed.) Citation

Lee, Jeeyeon, et al. "Immune-Related Adverse Events in Breast Cancer Patients Who Received Neoadjuvant Chemotherapy with Pembrolizumab: What Needs to Be Managed Before Surgery." Cancers, vol. 18, no. 6, 2026, p. 919, https://doi.org/10.3390/cancers18060919.